(Q24247192)

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Estimates of the worldwide incidence of eighteen major cancers in 1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

The adverse effect of treatment prolongation in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Cell production rates in human tissues and tumours and their significance. Part II: clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Chemoradiotherapy for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Meta-analysis of the literature or of individual patient data: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Neoadjuvant chemotherapy in locally advanced cervical cancer: two randomised studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced Bladder Cancer Overview Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

Has the influence of treatment duration on local control of carcinoma of the cervix been defined?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Randomized Trial of Neoadjuvant Cisplatin, Vincristine, Bleomycin, and Radical Hysterectomy Versus Radiation Therapy for Bulky Stage IB and IIA Cervical Cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001774.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD001774.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

15106161

1 reference

Consolidated OpenCitations Corpus – April 2017